phase 2
study 2
decitabine 1
rapamycin 1
relapsedrefractory 2
aml 2
proteasome 1
inhibition 1
myelodysplastic 1
syndromes 1
acute 2
myelogenous 1
leukemia 2
cell 1
lines 1
cladribine 1
cytarabine 1
arac 1
granulocyte 1
colony 1
stimulating 1
factor 1
gcsf 1
clag 1
regimen 1
simultaneous 1
escalating 1
doses 1
imatinib 1
mesylate 1
gleevec 1
antibody 1
therapy 1
myeloid 1
